Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Insulin (AERx) vs Aspart in Type 1 Diabetes
NCT00322257Phase 3Terminated
- Sponsor
- Novo Nordisk
- Start
- May 2006
- Primary completion
- Apr 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 3 trial of regular human insulin in type 1 diabetes mellitus (T1D), sponsored by Novo Nordisk. Started May 2006; status: terminated.
02
Drugs
regular human insulin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00322257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00322257.